CSL 0.46% $305.74 csl limited

Broker targets

  1. 2,032 Posts.
    lightbulb Created with Sketch. 501
    Morningstar has valued the stock at $207 (up from $200 immediately prior to release of full year results).
    They attribute approximately $57 of this $207 to the success of CSL112 (i.e. if it failed, they would removed $57 from share price valuation). They have a 50% chance of success on the CSL112 drug so I imagine if it became successful, Morningstar would add $57 to valuation.

    A while ago someone posted that Goldman Sachs have a price target of $225. Does anyone have updated reports or price targets from Goldman Sachs or other brokers?
 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$305.74
Change
-1.420(0.46%)
Mkt cap ! $147.7B
Open High Low Value Volume
$306.75 $307.16 $302.85 $128.0M 420.0K

Buyers (Bids)

No. Vol. Price($)
1 100 $305.20
 

Sellers (Offers)

Price($) Vol. No.
$305.80 500 1
View Market Depth
Last trade - 16.10pm 02/09/2024 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.